Post-approval studies (Phase 4)Not Yet RecruitingNCT07311551
What this trial is testing
A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)
Who this might be right for
Type 2 Diabetes
Bhavya Bhavya, MD 112